Searched for
NEW MIGRAINE TREATMENT
Study identifies 74 locations in human genome related to anxiety symptomsScientists have pinpointed 74 genetic locations linked to anxiety symptoms, with 39 being newly identified. This extensive research, involv...
What is ALS? 90 Day FiancĂ© star Jenny Slatten reveals emotional diagnosis update with husband Sumit SinghJenny Slatten, known for 90 Day Fiancé: The Other Way, has revealed that she has been diagnosed with Amyotrophic Lateral Sclerosis. Jenny s...
From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...
US market today: Pfizer posts strong first-quarter, sees boost from recent legal winsPfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...
Pfizer launches new medication for migraine treatmentIn a significant breakthrough for migraine sufferers in India, Pfizer has launched Rimegepant ODT, an innovative oral tablet that dissolves...
Alembic Pharmaceuticals gets USFDA nod for generic migraine treatment injectionAlembic Pharmaceuticals has achieved a pivotal milestone with the final green light from the US health authority for its generic Sumatripta...
Research says blood flow changes in eyes can influence visual symptoms of migraineThe research employed a non-invasive imaging technique called optical coherence tomography angiography (OCTA) to observe alterations in ret...
A hand-worn device can provide you relief from migraine pain without medicine: Here is how it works, costHyderabad-based pharmaceutical company, Dr Reddy's Laboratories, has launched Nerivio, a revolutionary wearable therapy device for the trea...
Surgery could be the answer to severe headaches caused by migraineThere is at least a 50% reduction in frequency and intensity of pain, with surgical removal providing long-term relief.
Dr Reddy's may file two new drugs with FDA by 2019The city-based pharma company is expected to file the New Drug Application (NDA)with US Food and Drug Administration with regard the migrai...
Zydus Cadila gets USFDA nod to market migraine drugZydus Cadila has received the final approval from the USFDA to market Eletriptan Hydrobromide tablets, 20 mg (base) and 40 mg (base).
Alembic Pharma gets US FDA nod for anti-migraine drug"The company has received approval from the USFDA for its Abbreviated New Drug Application for Zolmitriptan Orally Disintegrating Tablets, ...
Ajanta Pharma gets USFDA nod for migraine pain relief drugAjanta Pharma has received final approval for its generic version of acute migraine pain relief drug Zolmitriptan tablets from the US healt...
Dr Reddy’s goes beyond generic products, gets nod for two branded drugsThe approvals have come at a time when Indian drug companies are facing the FDA’s ire for non-compliance of good manufacturing process.
Dr Reddy's gets USFDA nod for migraine injectionThe company has received an approval from the US Food and Drug Administration (USFDA) for ZembraceSymTouch injection, DRL said in a stateme...
Jubilant Life Sciences gets USFDA nod for migraine treatment drugJubilant Life Sciences announced approval from the US health regulator for its generic version of Merck's acute migraine treatment medicine.
Dr Reddy's files three new drug applications with USFDAOf them, the two NDAs are the first dermatology applications submitted to the US regulator that were fully developed leveraging in-house ca...
Aurobindo Pharma gets USFDA nod for anti-migraine tabletsThe product which was tentatively approved by the FDA earlier, is ready for launch, a statement from Aurobindo said.
- Sun Pharma gets USFDA approval for migraine injection
Sun Pharma said it has received the USFDA approval for the launch of its generic Sumatriptan Succinate injections in the American market.
- Govt to share Lupin's migraine
The government's Department of Science and Technology (DST) has committed over Rs 10 crore to support drug maker Lupin's two clinical devel...